Follistatin UK: Complete Research Guide (2026)

For laboratory research use only. This page summarises published scientific literature on Follistatin in plain English, in a neutral research style. It is not medical advice and contains no guidance on doses, administration or human use.

Follistatin UK: Complete Research Guide (2026)

Disclaimer: This guide is for educational and research purposes only. Follistatin is a research peptide and glycoprotein. Always consult relevant regulatory bodies and conduct due diligence before use in any research context.

What is Follistatin?

Follistatin is a glycoprotein with a molecular weight of approximately 37 kDa in its mature form. It is an endogenous antagonist of activin and myostatin, two members of the transforming growth factor-beta (TGF-β) superfamily. The follistatin gene encodes a protein that is expressed in multiple tissues, including skeletal muscle, bone, liver, and reproductive tissues, where it exerts diverse biological effects through ligand-binding and antagonism.

Mechanism of Action: Activin and Myostatin Antagonism

Follistatin exerts its biological effects primarily through two mechanisms: direct binding to activin and myostatin ligands, rendering them biologically inactive.

Activin Antagonism

Activin is a dimeric cytokine that signals through type I and type II serine/threonine kinase receptors, ultimately activating the SMAD signalling pathway. In the reproductive system, activin stimulates FSH secretion. Follistatin binds activin with high affinity, preventing its interaction with cellular receptors and thereby inhibiting FSH production. This mechanism has made Follistatin an invaluable research tool for studying FSH regulation and reproductive endocrinology.

Myostatin Antagonism

Myostatin (also called growth differentiation factor-8, or GDF-8) is an autocrine/paracrine regulator of skeletal muscle growth that acts as a negative regulator—inhibiting muscle hypertrophy and myogenesis. Follistatin binds myostatin with high affinity, sequestering it and preventing its signalling through activin type II receptors on muscle cells. By antagonising myostatin, Follistatin permits increased muscle protein synthesis and growth. This is the mechanism underlying much of the recent research interest in Follistatin for muscle growth and wasting disorders.

Follistatin Variants: -288 and -315

The follistatin gene undergoes alternative splicing to produce two main isoforms:

Follistatin-315

The larger, 315-amino-acid isoform, produced when exon 2 is included. Follistatin-315 contains additional domains that confer higher-affinity binding to heparan sulfate proteoglycans, resulting in greater tissue localisation. This isoform may be more active in local tissue contexts.

Both isoforms effectively antagonise activin and myostatin, and the choice between them for research depends on experimental objectives.

Muscle Growth Research: Myostatin Inhibition and Hypertrophy

The most extensively studied application of Follistatin in research is its role in promoting skeletal muscle growth through myostatin antagonism.

Myostatin Inhibition Mechanisms

The muscle-promoting effects of Follistatin are mediated by its high-affinity binding to myostatin, preventing the latter from activating activin type II receptors on muscle cells. This permits sustained myogenic signalling and anabolic protein synthesis.

Fertility and Reproductive Research

Originally identified for its role in reproductive endocrinology, Follistatin continues to be an important research tool for understanding gonadal function:

Ovarian Follicle Development

Activin plays direct roles in ovarian follicle development and function. Follistatin’s antagonism of activin modulates these processes, making Follistatin a tool for investigating ovarian physiology and fertility.

Follistatin versus ACE-031: Myostatin Inhibition Strategies

ACE-031 is an alternative myostatin antagonist—a soluble activin type IIB receptor construct that binds and sequesters myostatin and related ligands. Comparison studies between Follistatin and ACE-031 reveal:

• Mechanism Differences: Follistatin directly binds the ligand; ACE-031 acts as a decoy receptor. Both are effective antagonists of myostatin.
• Ligand Specificity: Follistatin primarily targets activin and myostatin; ACE-031 binds multiple TGF-β family members, including activin B and other GDF ligands, potentially resulting in broader systemic effects.
• Muscle Growth Efficacy: Both promote muscle hypertrophy in preclinical models, with comparable or overlapping effects on lean mass increases.
• Research Context: The choice between them depends on whether selective myostatin/activin antagonism or broader TGF-β family inhibition is desired.

UK Legal Status and Sourcing

Follistatin is not a licensed pharmaceutical in the UK. It is supplied as a research glycoprotein by authorised chemical and biological suppliers. Researchers must:

• Verify institutional ethical approval for intended research.
• Source from reputable suppliers with documented purity, identity (mass spectrometry), and biological activity assays.
• Comply with Health and Safety Executive (HSE) regulations and institutional biosafety guidelines.
• Maintain accurate records of acquisition, storage, and use.

Conclusion

Limits of the evidence

Published findings come from specific study designs, often in cell systems or animals, and do not transfer automatically to other settings. A paper about a molecule is not proof that any particular batch has a given biological effect. Purity data show what is in a vial; they do not show sterility, safety or suitability for any use outside the laboratory.

Laboratory handling

• Store lyophilised powder sealed, cold (−20 °C for long-term storage), dry and protected from light.
• Let vials reach room temperature before opening to limit condensation.
• Prepare solutions with suitable laboratory solvents and calibrated equipment, and label each with lot number, concentration and date.
• Split solutions into single-use aliquots and avoid repeated freeze–thaw cycles.
• Use the peptide calculator for concentration arithmetic (mg/mL).

For laboratory research use only. Follistatin sold by Peptides Lab UK is supplied strictly for in vitro laboratory research. It is not for human or veterinary use, and nothing on this page is medical advice or guidance on administration. UK purchasers are responsible for complying with all applicable legislation.